Neurocrine Biosciences, Inc.
(NASDAQ : NBIX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.72%195.471.3%$541.08m
GILDGilead Sciences, Inc.
0.06%65.920.9%$360.62m
ALXNAlexion Pharmaceuticals, Inc.
0.28%108.842.0%$336.75m
ILMNIllumina, Inc.
-0.26%300.123.5%$305.76m
BIIBBiogen Inc.
0.45%237.171.3%$298.34m
CELGCelgene Corporation
0.35%98.721.3%$286.48m
SRPTSarepta Therapeutics, Inc.
-1.22%85.9614.6%$183.41m
VRTXVertex Pharmaceuticals Incorporated
-0.18%177.241.9%$174.37m
AAgilent Technologies, Inc.
-0.84%76.501.6%$171.94m
REGNRegeneron Pharmaceuticals, Inc.
0.31%286.782.6%$171.72m
EXASExact Sciences Corporation
1.54%106.0224.1%$133.89m
ACADACADIA Pharmaceuticals Inc.
-2.83%42.7713.9%$114.14m
INCYIncyte Corporation
0.34%78.612.5%$85.67m
BMRNBioMarin Pharmaceutical Inc.
-0.07%74.164.3%$70.29m
IONSIonis Pharmaceuticals, Inc.
-0.13%65.058.2%$63.44m

Company Profile

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.